Neck recurrence from thyroid carcinoma: Serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment

Clinical Endocrinology

Volumn 62, Issue 3, 2005, Pages 376-379

  Bachelot, Anne ^a   Leboulleux, Sophie ^a   Baudin, Eric ^a   Hartl, Dana M ^a   Caillou, Bernard ^a   Travagli, Jean Paul ^a   Schlumberger, Martin ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; LIOTHYRONINE; RADIOACTIVE IODINE; THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK METASTASIS; PRIORITY JOURNAL; SCHOOL CHILD; SUBTOTAL THYROIDECTOMY; THYROGLOBULIN BLOOD LEVEL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES; THYROGLOBULIN; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 15044363046     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02228.x     Document Type: Article

References (29)

1. Schlumberger, M.J. (1998) Papillary and follicular thyroid carcinoma. New England Journal of Medicine, 338, 297-306.
2. De Groot, L.J., Kaplan, E.L., McCormick, M. & Straus, F.H. (1990) Natural history, treatment, and course of papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 71, 414-424.
3. Scheumann, G.F.W., Gimm, O., Wegener, G., Hundeshagen, H. & Dralle, H. (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World Journal of Surgery, 18, 559-568.
4. Noguchi, S., Murakami, N., Yamashita, H., Toda, M. & Kawamoto, H. (1998) Papillary thyroid carcinoma. Modified radical neck dissection improves prognosis. Archives of Surgery, 133, 276-280.
5. Tubiana, M., Schlumberger, M., Rougier, P., Laplanche, A., Benhamou, E., Gardet, P., Caillou, B., Travagli, J.R & Parmentier, C. (1985) Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer, 55, 794-804.
6. Mazzaferri, E.L. & Jhiang, S.M. (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine, 97, 418-428.
7. Grebe, S.K.G. & Hay, I.D. (1996) Thyroid cancer nodal metastases. Biologic significance and therapeutic considerations. Surgical Oncology Clinics of North America, 5, 43-63.
8. Maxon, H.R., Thomas, S.R., Hertzberg, VS., Kereiakes, J.G., Chen, I.W., Sperling, M.I. & Saenger, E.L. (1983) Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. New England Journal of Medicine, 309, 937-941.
9. Pacini, F., Cetani, F., Miccoli, P., Mancusi, F., Ceccarelli, C., Lippi, F., Martino, E. & Pinchera, A. (1994) Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World Journal of Surgery, 18, 600-604.
10. Coburn, M., Teates, D. & Wanebo, H.J. (1994) Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131). Annals of Surgery, 219, 587-595.
11. 131I) and probe-guided surgery for persistent or recurrent thyroid car cinoma. Journal of Clinical Endocrinology and Metabolism, 83, 2675-2680.
12. Thyroid gland (ICD-OC73) (1992) In: P. Hermanek, L.H. Sobin, eds. TNM Classification of Malignant Tumors, 4th edn, 2nd revision. Springer-Verlag, Berlin, 35-37.
13. Tenenbaum, F., Corone, C., Schlumberger, M. & Parmentier, C. (1996) Thyroglobulin measurement and postablative iodine-131 total body scan after total thyroidectomy for differentiated thyroid carcinoma in patients with no evidence of disease. European Journal of Cancer, 32A, 1262.
14. Schlumberger, M. & Baudin, E. (1998) Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. European Journal of Endocrinology, 138, 249-252.
15. Bachelot, A., Cailleux, A.F., Klain, M., Baudin, E., Ricard, M., Bellon, N., Caillou, B., Travagli, J.P. & Schlumberger, M. (2002) Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid, 12, 707-711.
16. Pacini, F., Lari, R., Mazzeo, S., Grasso, L., Taddei, D. & Pinchera, A. (1985) Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clinical Endocrinology, 23, 405-411.
17. Schlumberger, M.J., Challeton, C., De Vathaire, F., Travagli, J.P., Gardet, P., Lumbroso, J.D., Francese, C., Fontaine, F., Ricard, M. & Parmentier, C. (1996) Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. Journal of Nuclear Medicine, 37, 598-605.
18. Demers, L.M. & Spencer, C.A. (7-13-2002) Laboratory support for the diagnosis and monitoring of thyroid disease, http://www.nacb.org/lmpg/thyroid/ LMPH.stm.
19. Pacini, F., Lippi, F., Formica, N., Elisei, R., Anelli, S., Ceccarelli, C. & Pinchera, A. (1987) Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with undetectable serum thyroglobulin levels. Journal of Nuclear Medians, 28, 1888-1891.
20. Schlumberger, M., Arcangioli, O., Piekarski, J.D., Tubiana, M. & Parmentier, C. (1988) Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. Journal of Nuclear Medicine, 29, 1790-1794.
21. Sherman, S.I., Tielens, E.T., Sostre, S., Wharam, M.D. & Ladenson, P.W. (1994) Clinical utility of post treatment radioiodine scans in the management of patients with thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 78, 629-634.
22. Pineda, I.D., Lee, T., Ain, K., Reynolds, J.C. & Robbins, I. (1995) Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. Journal of Clinical Endocrinology and Metabolism, 80, 1488-1492.
23. Cailleux, A.F., Baudin, E., Travagli, J.P., Ricard, M. & Schlumberger, M. (2000) Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? Journal of Clinical Endocrinology and Metabolism, 85, 175-178.
24. Robbins, R.J., Thomas Chon, J., Fleisher, M., Larson, S.M. & Turtle, R.M. (2002) Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? Journal of Clinical Endocrinology and Metabolism, 87, 3242-3247.
25. Frasoldati, A., Pesenti, M., Gallo, M., Caroggio, A., Salvo, D. & Valcavi, R. (2003) Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer, 97, 90-96.
26. Pacini, F., Molinaro, E., Castagna, M.G., Agate, L., Elisei, R., Ceccarelli, C., Lippi, F., Taddei, D., Grasso, L. & Pinchera, A. (2003) Recombinant human TSH-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 88, 3668-3673.
27. Torlontano, M., Attard, M., Crocetti, U., Tumino, S., Bruno, R., Costante, G., D'Azzo, G., Meringolo, D., Ferretti, E., Sacco, R., Arturi, F. & Filetti, S. (2004) Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. Journal of Clinical Endocrinology and Metabolism, 89, 3402-3407.
28. 18F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 29, 641-647.
29. Chin, B.B., Patel, P., Cohade, C., Ewertz, M., Wahl, R. & Ladenson, P. (2004) Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 89, 91-95.